Stock Traders Purchase Large Volume of Put Options on SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) saw unusually large options trading activity on Wednesday. Stock investors bought 148,898 put options on the stock. This represents an increase of 204% compared to the typical daily volume of 48,910 put options.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Institutional investors have recently modified their holdings of the company. Dynamic Wealth Strategies LLC grew its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the 4th quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after purchasing an additional 80 shares during the last quarter. Capital Investment Advisory Services LLC boosted its position in SPDR S&P Biotech ETF by 4.0% in the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after buying an additional 81 shares in the last quarter. Commerce Bank boosted its position in SPDR S&P Biotech ETF by 2.8% in the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after buying an additional 90 shares in the last quarter. Compass Ion Advisors LLC grew its stake in SPDR S&P Biotech ETF by 2.6% during the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock worth $474,000 after buying an additional 97 shares during the last quarter. Finally, AdvisorNet Financial Inc raised its stake in shares of SPDR S&P Biotech ETF by 7.3% in the third quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock valued at $147,000 after acquiring an additional 100 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 0.8%

Shares of XBI opened at $125.60 on Thursday. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The company has a 50-day simple moving average of $124.54 and a 200-day simple moving average of $110.70. The company has a market capitalization of $8.39 billion, a PE ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.